vs

Side-by-side financial comparison of Realty Income (O) and ResMed (RMD). Click either name above to swap in a different company.

Realty Income is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.0× ResMed). ResMed runs the higher net margin — 27.6% vs 19.9%, a 7.7% gap on every dollar of revenue. On growth, Realty Income posted the faster year-over-year revenue change (11.0% vs 11.0%). Over the past eight quarters, Realty Income's revenue compounded faster (8.6% CAGR vs 7.8%).

Realty Income Corporation is a real estate investment trust that invests in free-standing, single-tenant commercial properties in the United States, the United Kingdom, and six other countries in Europe. These properties are subject to NNN Leases. The company is organized in Maryland with its headquarters in San Diego, California.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

O vs RMD — Head-to-Head

Bigger by revenue
O
O
1.0× larger
O
$1.5B
$1.4B
RMD
Growing faster (revenue YoY)
O
O
+0.0% gap
O
11.0%
11.0%
RMD
Higher net margin
RMD
RMD
7.7% more per $
RMD
27.6%
19.9%
O
Faster 2-yr revenue CAGR
O
O
Annualised
O
8.6%
7.8%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
O
O
RMD
RMD
Revenue
$1.5B
$1.4B
Net Profit
$296.1M
$392.6M
Gross Margin
61.8%
Operating Margin
21.7%
34.6%
Net Margin
19.9%
27.6%
Revenue YoY
11.0%
11.0%
Net Profit YoY
48.3%
13.9%
EPS (diluted)
$0.32
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
O
O
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.5B
$1.4B
Q3 25
$1.5B
$1.3B
Q2 25
$1.4B
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$1.3B
$1.3B
Q3 24
$1.3B
$1.2B
Net Profit
O
O
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$296.1M
$392.6M
Q3 25
$315.8M
$348.5M
Q2 25
$196.9M
$379.7M
Q1 25
$249.8M
$365.0M
Q4 24
$199.6M
$344.6M
Q3 24
$269.5M
$311.4M
Gross Margin
O
O
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
O
O
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
21.7%
34.6%
Q3 25
23.2%
33.4%
Q2 25
15.8%
33.7%
Q1 25
19.3%
33.0%
Q4 24
16.5%
32.5%
Q3 24
21.5%
31.6%
Net Margin
O
O
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
19.9%
27.6%
Q3 25
21.5%
26.1%
Q2 25
14.0%
28.2%
Q1 25
18.1%
28.3%
Q4 24
14.9%
26.9%
Q3 24
20.2%
25.4%
EPS (diluted)
O
O
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$0.32
$2.68
Q3 25
$0.35
$2.37
Q2 25
$0.22
$2.58
Q1 25
$0.28
$2.48
Q4 24
$0.23
$2.34
Q3 24
$0.30
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
O
O
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$434.8M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$39.4B
$6.3B
Total Assets
$72.8B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
O
O
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$434.8M
$1.4B
Q3 25
$417.2M
$1.4B
Q2 25
$800.4M
$1.2B
Q1 25
$319.0M
$932.7M
Q4 24
$445.0M
$521.9M
Q3 24
$397.0M
$426.4M
Total Debt
O
O
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Stockholders' Equity
O
O
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$39.4B
$6.3B
Q3 25
$39.1B
$6.1B
Q2 25
$39.2B
$6.0B
Q1 25
$39.0B
$5.5B
Q4 24
$38.8B
$5.3B
Q3 24
$38.5B
$5.2B
Total Assets
O
O
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$72.8B
$8.5B
Q3 25
$71.3B
$8.3B
Q2 25
$71.4B
$8.2B
Q1 25
$69.8B
$7.6B
Q4 24
$68.8B
$7.1B
Q3 24
$68.5B
$7.2B
Debt / Equity
O
O
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
O
O
RMD
RMD
Operating Cash FlowLast quarter
$1.2B
Free Cash FlowOCF − Capex
$1.2B
FCF MarginFCF / Revenue
77.6%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
4.06×
TTM Free Cash FlowTrailing 4 quarters
$3.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
O
O
RMD
RMD
Q2 26
Q1 26
Q4 25
$1.2B
$339.7M
Q3 25
$943.1M
$457.3M
Q2 25
$1.1B
$538.8M
Q1 25
$787.5M
$578.7M
Q4 24
$972.0M
$308.6M
Q3 24
$841.5M
$325.5M
Free Cash Flow
O
O
RMD
RMD
Q2 26
Q1 26
Q4 25
$1.2B
$311.2M
Q3 25
$909.9M
$414.4M
Q2 25
$1.0B
$508.2M
Q1 25
$764.6M
$557.9M
Q4 24
$935.8M
$288.0M
Q3 24
$807.9M
$307.7M
FCF Margin
O
O
RMD
RMD
Q2 26
Q1 26
Q4 25
77.6%
21.9%
Q3 25
61.9%
31.0%
Q2 25
73.3%
37.7%
Q1 25
55.4%
43.2%
Q4 24
69.8%
22.5%
Q3 24
60.7%
25.1%
Capex Intensity
O
O
RMD
RMD
Q2 26
Q1 26
Q4 25
3.3%
2.0%
Q3 25
2.3%
3.2%
Q2 25
1.9%
2.3%
Q1 25
1.7%
1.6%
Q4 24
2.7%
1.6%
Q3 24
2.5%
1.5%
Cash Conversion
O
O
RMD
RMD
Q2 26
Q1 26
Q4 25
4.06×
0.87×
Q3 25
2.99×
1.31×
Q2 25
5.39×
1.42×
Q1 25
3.15×
1.59×
Q4 24
4.87×
0.90×
Q3 24
3.12×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

O
O

Product And Service Retail$900.8M61%
Other$531.5M36%

RMD
RMD

Segment breakdown not available.

Related Comparisons